新型生物标志物在脓毒症中应用的研究进展

Research Progress in the Application of Emerging Biomarkers in Sepsis

脓毒症是一种危及生命的疾病,指机体对微生物病原体的反应失调导致炎性反应失衡和多器官功能衰竭。脓毒症早期识别及处理至关重要。近年来,逐渐发现多种新型生物标志物,这些生物标志物的单独或联合检测为脓毒症早期诊断和预后评估带来新的机遇,且有望拓宽脓毒症的治疗思路。本文就相关生物标志物的近期研究展开论述。

Sepsis is a life-threatening disease,which refers to the imbalance of inflammation and multiple organ failure caused by the body's uncoordinated response to microbial pathogens.Early identification and management of sepsis is very important.In recent years,many new biomarkers have been gradually discovered.The single or combined detection of these biomarkers brings new opportunities for the early diagnosis and prognosis evaluation of sepsis,and is expected to broaden the treatment ideas of sepsis.This paper discusses the recent research on related biomarkers.